fda compounding semaglutide enforcement news november 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non- FDA-approved compounded "semaglutide" fda compounding semaglutide enforcement november

Weight Loss Journey and Expectations Every weight loss journey is different, and if youre curious about how much weight you lose, the amount will depend on your starting weight, dose, and how your body responds to treatment

Pharmaceutical companies establish a Wholesale Acquisition Cost (WAC), which serves as the official list price before insurance negotiations

GLP-1 medications are primarily used to treat diabetes and aid weight loss by mimicking a natural hormone in the gut, helping regulate blood sugar levels and slowing digestion

Some employer plans still exclude weight loss medications entirely

The medication has reached therapeutic levels, side effects have subsided, and the metabolic adaptations are working at full capacity

This helps ensure the medication is working as intended and allows for timely dose adjustments